Decheng Capital — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
ImmPACT Bio USA Inc.Apr 2024SEC filingmedium confidence
West Hills, US
Board seatXiangmin Cui· per SEC Form D · $141.8M raise · filed Apr 2024
Co-investorsNovartis Venture FundRMGP Biopharma Investment FundvenBio Global Strategic
LevitasMar 2024SEC filingmedium confidence
San Francisco, US
Utkan Demirci(Director)Lars Steinmetz(Director)Martin Pieprzyk(Executive Officer)
BoardXiangmin Cui(Director)Victor Tong(Director)
Board seatVictor Tong, Jr.· per SEC Form D · $25.1M raise · filed Apr 2024
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.